Invetx.com

Invetx Announces $15 Million Series A Financing and Industry …

WEBInvetx’s Market Research Study Reveals Nearly 40% of Dogs in the U.S. Suffer from Chronic Osteoarthritis/Pain. Boston, MA, November 29, 2023 – Invetx, a …

Actived: 5 days ago

URL: https://www.invetx.com/invetx-announces-15-million-series-a-financing-and-industry-leading-partnerships-for-animal-biopharmaceutical-development/

Invetx Completes Development of Canine and Feline Half-Life …

WEBLong-Acting Therapeutics Make Chronic Diseases More Manageable and Provide Better Value for Pet Owners. Boston, MA- July 25, 2023 – Invetx, a pioneer in …

Category: Health Go Health

Invetx’s Market Research Study Reveals Nearly 40% of Dogs in the …

WEBPet Owners Would Pay Premium for Longer-Acting Therapeutics to Reduce Veterinary Visits and Ensure Continuous Treatment. Boston, MA, November 29, 2023 – …

Category: Health Go Health

Former Head of Boehringer Ingelheim Animal Health, Dr. Joachim …

WEBBOSTON, Mass. – January 6, 2021 – Invetx, a pioneer in protein-based therapeutics for animal health, announced today that Dr. Joachim Hasenmaier has joined the company’s …

Category: Health Go Health

Invetx Announces Initiation of First Clinical Study in Dogs with IVX …

WEBCompany Appoints Dr. Robert Zolynas as Vice President, Clinical Development & Regulatory Affairs. Boston, MA- September 20, 2021- Invetx, a pioneer …

Category: Health Go Health

AbCellera and Invetx Expand Multi-Year Antibody Discovery …

WEBVANCOUVER, British Columbia, and BOSTON, November 19, 2020 – AbCellera, a technology company that searches, decodes, and analyzes natural immune systems to …

Category: Health Go Health

News & Press Releases

WEBBoston, MA, November 29, 2023 – Invetx, a pioneer in protein-based therapeutics for animal health, announced results of a market research study showing …

Category: Health Go Health

Invetx Discovery Platform

WEBIN･VET･X (ɪnˈvɛtɛks) noun. The leading innovative veterinary therapeutics company, focused on biopharmaceuticals that bring the best of human biotechnology to …

Category: Health Go Health

Boehringer Ingelheim and Invetx Announce Strategic …

WEBCollaboration Focused on Discovery, Development and Commercialization of Novel Veterinary Medicines Ingelheim, Germany and Boston, MA- September 27, …

Category: Medicine Go Health

Twist Bioscience Partners with Invetx to Deliver Best-in-Class …

WEBInvetx’s Market Research Study Reveals Nearly 40% of Dogs in the U.S. Suffer from Chronic Osteoarthritis/Pain. Boston, MA, November 29, 2023 – Invetx, a …

Category: Health Go Health

Invetx Announces Industry-Leading Antibody Discovery Platform …

WEBPlatform Leverages Best-in-Class Technologies from AbCellera, Twist Bioscience and WuXi Biologics. BOSTON, Mass. – July 16, 2020 – Invetx, a pioneer in …

Category: Health Go Health

Twist Bioscience Expands Partnership with Invetx to Include …

WEBNovember 18, 2021 – Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using …

Category: Health Go Health

Invetx Announces Completion of $25.5 Million Series A Financing …

WEBInvetx’s Market Research Study Reveals Nearly 40% of Dogs in the U.S. Suffer from Chronic Osteoarthritis/Pain. Boston, MA, November 29, 2023 – Invetx, a …

Category: Health Go Health

Invetx Appoints Dr. Marcus Remmers, Novo Holdings Partner and …

WEBInvetx’s Market Research Study Reveals Nearly 40% of Dogs in the U.S. Suffer from Chronic Osteoarthritis/Pain. Boston, MA, November 29, 2023 – Invetx, a …

Category: Health Go Health

Invetx Announces Oversubscribed Series B Financing of $60.5 …

WEBBoston, MA- May 10, 2022- Invetx, a pioneer in protein-based therapeutics for animal health, today announced that it has raised $60.5 million in an oversubscribed Series B …

Category: Health Go Health